A new product segment for ATCC, the quality control solution addresses the critical need for verification and assessment in covid-19 molecular diagnostic testing for clinical laboratories and test manufacturers.
Read More
The Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein and may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for covid-19.
Read More
The covid-19 assay utilizes Twist Bioscience’s ability to rapidly develop virus-specific panels by DNA synthesis and Biotia’s comprehensive data analysis software and reporting capabilities.
Read More
The LigoLab LIS & RCM Operating Platform is fully integrated and features targeted automation that enables users to identify and process thousands of uninsured covid-19 patients in just minutes.
Read More
The Omnipath Combi SARS-CoV-2 IgG ELISA detects and quantifies antibodies against the coronavirus and increases the University of Oxford’s testing capacity to up to 50,000 tests per day.
Read More